University of Hawaiʻi Cancer Center’s Christa Braun-Inglis was awarded the 2024 David King Community Clinical Scientist Award by the Association of Community Cancer Centers (ACCC). Braun-Inglis was recognized for her dedication to cancer research and education. Her focus and commitment to assisting advanced practice providers (APPs) overcome barriers to their participation in clinical trials has led to a change in national policies.
Related UH News story: National Cancer Institute ‘s Director’s Award for UH researcher
Braun-Inglis is an oncology researcher whose research identified several challenges APPs face. She has made notable progress in expanding their role in National Cancer Institute (NCI) clinical trials, aiming to enhance their engagement and representation. Her clinical trial research includes increasing diversity, optimizing cancer care delivery, and focusing on specific areas such as breast cancer.
“It is such an honor to receive the ACCC 2024 David King Community Clinical Scientist Award!” said Braun-Inglis, who was also awarded the 2023 for her achievements in expanding the roles of APPs. “ACCC‘s dedication to multidisciplinary, team-based care continues to shine by acknowledging the important role advanced practice providers can play in clinical research.”
The ACCC‘s endorsement of Braun-Inglis’ proposal for an APP and clinical trials survey initiated national policy changes to broaden the scope of APP roles in clinical trials and implement a novel care delivery research concept. This concept integrates APPs across the NCI Community Oncology Research Program.
Braun-Inglis was honored at the 2024 ACCC Awards Ceremony on March 1 in Washington, D.C., during the organization’s 50th Annual Meeting and Cancer Center Business Summit. The award is named in honor of the late Dr. David K. King, a former president of ACCC, for his lifelong dedication to caring for those with cancer and advocacy for access to quality care.
